IOVA FY 2011 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$19M

Operating Income

-$21M

Net Income

-$26M

EPS (Diluted)

$-33.84

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$568,430

Total Liabilities

$13M

Stockholders' Equity

-$13M

Cash & Equivalents

$510,217

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$19M	$0	—
Operating Income	-$21M	-$815,000	-2503.4%
Net Income	-$26M	-$2M	-1497.9%